To examine the efficacy of the strategy to selectively eradicate prostate cancer cells carrying activated Akt in vivo, we first employed xenografts of PC3 cells in athymic nude mice and studied the effect of PEITC and rapamycin on the growth of tumors induced by PC3 cells (Figure 2E). This evidence concerns the gene AKT1 and prostate cancer.